Novo Nordisk (NVO)

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

NVO stock data


2 Feb 22
17 May 22
31 Dec 22
Quarter (USD) Dec 21 Dec 20 Dec 19 Dec 18
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
7.4% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 867 788 +10.0%
Opened positions 147 103 +42.7%
Closed positions 68 37 +83.8%
Increased positions 255 273 -6.6%
Reduced positions 286 227 +26.0%
13F shares Current Prev Q Change
Total value 14.7B 12.66B +16.1%
Total shares 131.35M 131.85M -0.4%
Total puts 694.21K 443.2K +56.6%
Total calls 1.26M 1.08M +17.4%
Total put/call ratio 0.5 0.4 +33.5%
Largest owners Shares Value Change
Renaissance Technologies 19.12M $2.14B -11.7%
Fisher Asset Management 15.94M $1.79B -1.5%
BAC Bank Of America 7.31M $819.19M -2.0%
Loomis Sayles & Co L P 6.16M $689.57M -4.4%
Capital International Investors 5.65M $631.33M +3.3%
Fayez Sarofim & Co 4.83M $541.21M -1.8%
Folketrygdfondet 4.42M $495.03M -6.3%
STT State Street 3.72M $416.85M -3.8%
State Farm Mutual Automobile Insurance 3.48M $389.66M 0.0%
BLK Blackrock 3.46M $387.98M +1.3%
Largest transactions Shares Bought/sold Change
Renaissance Technologies 19.12M -2.52M -11.7%
WCM Investment Management 2.49M +2.49M NEW
Millennium Management 240.02K -549.37K -69.6%
Arrowstreet Capital, Limited Partnership 921.74K +533.8K +137.6%
Adage Capital Partners GP, L.L.C. 525K +525K NEW
Two Sigma Investments 335.57K -439.53K -56.7%
Citadel Advisors 45.97K -312.21K -87.2%
Folketrygdfondet 4.42M -295.63K -6.3%
Clark Capital Management 3.25K -288.85K -98.9%
Loomis Sayles & Co L P 6.16M -282.26K -4.4%

Content analysis

8th grade Avg
New words: acid, adolescent, advice, alia, Alzheimer, Aurobindo, back, began, Beta, Boehringer, channel, CHMP, clarify, collaborative, comparison, counterpart, CSO, Deloitte, Department, Dicerna, direct, direction, disagreement, disclaimer, dismissed, DMCC, EMA, Endocrinology, endorsed, ESG, FDI, fermentation, forecasted, fourth, Germany, Glaxo, hand, Hospital, Hotline, Icosema, Ingelheim, interference, Lange, letter, longer, Mackay, mandatory, Martin, mathematical, methodology, MHRA, modestly, modified, newly, operationally, OSI, outpatient, overweight, overwhelming, Oxford, platform, Poulsen, preliminary, principle, procedure, proffered, Prosidion, purification, PwC, quantify, recovery, RESERVED, restore, reversal, reverse, ribonucleic, Rio, RNAi, rollout, rotation, royalty, satisfaction, Schindler, scope, screening, submission, Sun, Sweden, syringe, system, unbilled, uninsured, University, vaccination, valuation, Wegovy, whistleblowing, written, yearly
Removed: affiliate, applied, Astra, billed, Brexit, CAD, carried, central, Chairmanship, CNY, creating, CV, delivered, DEVOTE, discontinued, EUR, exit, expert, GBP, hedge, Hewitt, hypoglycaemia, IDegLira, Inflation, interim, invest, JPY, Latin, lease, Liz, low, lower, modest, Nationalbank, notify, penetration, preference, recurring, showed, successful, TABULAR, withdrawal, writing, Zeneca
No filings


Drug delivery device with information capture
30 Nov 20
A drug delivery device is provided comprising or adapted to receive a cartridge with an axially displaceable piston.
Power Unit for Drug Delivery Device
25 Nov 20
The present invention provides a power unit (1) for a drug delivery device as well as methods for providing and mounting the power unit (1) in the drug delivery device.
An Injection Device With Needle Cleaning
18 Nov 20
The invention relates to a medical injection device having a needle cannula for multiple use and which needle cannula is cleaned between subsequent injections.
Drug Injection Device with Deflectable Transducer
18 Nov 20
The present invention provides a drug injection device (100, 100′, 100″) comprising a first element (130) and a second element (102, 102′, 102″) configured to undergo movement relative to each other corresponding to an action performed on or by the drug injection device (100, 100′, 100″), wherein the first element (130) comprises serially disposed protrusions (133), and wherein the second element (102, 102′, 102″) comprises a second element base and a deflectable transducer (170, 170′, 170″).
Stable multi-dose compositions comprising an antibody and a preservative
16 Nov 20
The invention relates to stable, multi-dose liquid compositions containing proteins, in particular, but not exclusively stable antibodies, and to the use of said compositions in therapy, in particular for the subcutaneous delivery of said stable protein.